• Home
  • Training
  • Innovations in Drug Repurposing and Target Validation

Innovations in Drug Repurposing and Target Validation

Category: Course / Workshop

Location: Online

Registration Deadline: 25/11/2024

Date: 26/11/2024

Target Audience: Members of universities and academic research institutions, i.e., scientists, students, lab technicians, and professionals of knowledge and technology transfer in life sciences. Members of SMEs and companies focused on drug discovery and therapeutics.

Register HereArrow right

The HT Centre for Innovation and Technology Transfer (CITT) is launching its third online workshop on the topic of drug repurposing.

Together with Silvano Coletti (CEO Chelonia SA, Founder DrugReKindle), Andrea Beccari (Vice President EXSCALATE, Dompé farmaceutici SpA), and Paul Fehlner (Co-founder and CEO of reVision Therapeutics; Advisory board member DrugReKindle), we will explore drug repurposing, its advantages and limitations, and the wide range of applications it offers to researchers and industry professionals alike.

This workshop will address the practical aspects of drug repurposing, using an AI-based tool that guides users in identifying available drugs and mechanisms of action for their therapeutic target.

We will also navigate the complexities of patent-related aspects in drug discovery and repurposing

Join us online (via Zoom) on 26 November 2024, from 3 to 4.30 pm.

Registrations will close on 25 November. You will then receive the link to connect remotely via mail.

For more information, reach out to techtransferHT@fht.org.

Speakers